ABBV ▲ +1.5% - AbbVie Inc.
$ABBV - New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
11-OCT-2026 01:01 PM ET
Share this post
More filings for $ABBV
ABBV ▼ -0.3% - AbbVie Inc.Oct 30, 2026ABBV ▼ -0.3% - AbbVie Inc.Oct 30, 2026ABBV ▼ -0.3% - AbbVie Inc.Oct 30, 2026ABBV ▼ -0.9% - AbbVie Inc.Oct 28, 2026ABBV ▲ +0.1% - AbbVie Inc.Oct 26, 2026ABBV ▲ +0.5% - AbbVie Inc.Oct 23, 2026
View full $ABBV filing history →💬 Comments
Loading comments…
Leave a comment